Search
  • BioBoom

Sorrento Therapeutics: Two Month News Recap

Updated: Aug 1

It has been quite an eventful month of news for Sorrento Therapeutics, and since this site just went live, I thought it would be nice to do a two month news recap instead of 1 month recap. First link above photo directs you to the Sorrento Therapeutics website, and below the photo you have links to articles that did a good writeup on the news release. Next post will have a tentative timeline for all these events to actually get the GO from the FDA. Don't forget to sign up for the newsletter and become a member of this growing community of biotech investors/traders.


July 29, 2020


Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva

https://www.fiercebiotech.com/medtech/sorrento-picks-up-color-changing-covid-19-saliva-test-built-by-columbia-university



Jul 24, 2020


Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

https://smartpharmtx.com/gene-encoded-antibodies-for-coronavirus




Jul 20, 2020


FDA clears Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19

https://www.targetedonc.com/view/fda-approves-atezolizumab-triplet-regimen-for-treatment-of-advanced-braf-mutant-melanoma



July 01, 2020


Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2

https://pharmashots.com/press-releases/sorrento-announces-selection-of-t-viva-19-as-targeted-protein-vaccine-candidate-for-sars-cov-2/


https://www.biorxiv.org/content/10.1101/2020.06.29.178616v1.full.pdf



Jun 12, 2020

Sorrento Announces Full Repayment of Outstanding Term Loans



8k Of full Repayment Of Loans

https://investors.sorrentotherapeutics.com/static-files/7e1c2331-b5ab-4aaa-b155-a758fccb8366



Jun 10, 2020

Sorrento Announces It Has Submitted an Emergency Use Authorization (EUA) Application for the COVI-TRACK Diagnostic Test for the Detection of Antibodies to SARS-CoV-2

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm?lid=691172&lpcd=QKP



Jun 05, 2020

Sorrento COVIDTRAP™(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro



https://www.biospace.com/article/releases/sorrento-develops-sti-4398-covidtrap-protein-for-potential-prevention-and-treatment-of-sars-cov-2-coronavirus-disease-covid-19-/


698 views
 
  • Facebook
  • Twitter

©2020 by BiotechBoom.org(TM)